BridgeMD
New treatment option for Tolerance
Official title Risk Factors for Poor Tolerance of Ureteral Double-J Stent
ClinicalTrials.gov ID: NCT06815107
What this study is testing
- What it's testing
- The placement of a Ureteral Double-J Stent as an emergency treatment or preparation for endoscopy after Colic nephritis is very frequent. It is often poorly supported, most often by young patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- patient over 18 years old
- patient who need Ureteral Double-J Stenting
You likely can't join if
- patient under 18 years old,
- Iterative change,
- understanding disorder,
- inability to answer the questionnaire,
- refusal of the patient,
- long-term Ureteral Double-J Stenting (more than 6 month),
See the full eligibility criteria
- patient over 18 years old
- patient who need Ureteral Double-J Stenting
- patient under 18 years old,
- Iterative change,
- understanding disorder,
- inability to answer the questionnaire,
- refusal of the patient,
- long-term Ureteral Double-J Stenting (more than 6 month),
- active cancer.
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.